Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Journal of Wound Care
|
January 11, 2014
W.A.R. scores in patients with chronic leg ulcers: results of a multicentre study
F Jockenhöfer, H Gollnick, Katharina Herberger, et al.
The British Journal of Dermatology
|
January 22, 2021
Most rare subtypes of cutaneous lymphoma display variable CD30 expression: analysis of the German Cutaneous Lymphoma Network
U Wehkamp, C Mitteldorf, S Stendel, et al.
Allergy
|
December 7, 2011
Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis
J M Jensen, A Scherer, C Wanke, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
October 10, 2014
[Current detection rates of multiresistant gram negative bacteria (3MRGN, 4MRGN) in patients with chronic leg ulcers]
F Jockenhöfer, H Gollnick, K Herberger, et al.
The British Journal of Dermatology
|
March 24, 2000
Teaching non-specialist health care professionals how to identify the atypical mole syndrome phenotype: a multinational study
J A Bishop, M Bradburn, W Bergman, et al.
Journal of Cancer Research and Clinical Oncology
|
June 23, 2017
Tumor vascularization and clinicopathologic parameters as prognostic factors in merkel cell carcinoma
A Bob, F Nielen, J Krediet, et al.
Gut
|
October 14, 2004
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression
J Wehkamp, J Harder, M Weichenthal, et al.
Journal of Medical Genetics
|
June 1, 2005
Analysis of RUNX1 binding site and RAPTOR polymorphisms in psoriasis: no evidence for association despite adequate power and evidence for linkage
P Stuart, R P Nair, G R Abecasis, et al.
The British Journal of Dermatology
|
February 3, 2016
Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB-IVA mycosis fungoides/Sézary syndrome
F Child, P L Ortiz-Romero, R Alvarez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2011
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial
F Egberts, R Gutzmer, S Ugurel, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Journal of Wound Care
|
January 11, 2014
W.A.R. scores in patients with chronic leg ulcers: results of a multicentre study
F Jockenhöfer, H Gollnick, Katharina Herberger, et al.
The British Journal of Dermatology
|
January 22, 2021
Most rare subtypes of cutaneous lymphoma display variable CD30 expression: analysis of the German Cutaneous Lymphoma Network
U Wehkamp, C Mitteldorf, S Stendel, et al.
Allergy
|
December 7, 2011
Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis
J M Jensen, A Scherer, C Wanke, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
October 10, 2014
[Current detection rates of multiresistant gram negative bacteria (3MRGN, 4MRGN) in patients with chronic leg ulcers]
F Jockenhöfer, H Gollnick, K Herberger, et al.
The British Journal of Dermatology
|
March 24, 2000
Teaching non-specialist health care professionals how to identify the atypical mole syndrome phenotype: a multinational study
J A Bishop, M Bradburn, W Bergman, et al.
Journal of Cancer Research and Clinical Oncology
|
June 23, 2017
Tumor vascularization and clinicopathologic parameters as prognostic factors in merkel cell carcinoma
A Bob, F Nielen, J Krediet, et al.
Gut
|
October 14, 2004
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression
J Wehkamp, J Harder, M Weichenthal, et al.
Journal of Medical Genetics
|
June 1, 2005
Analysis of RUNX1 binding site and RAPTOR polymorphisms in psoriasis: no evidence for association despite adequate power and evidence for linkage
P Stuart, R P Nair, G R Abecasis, et al.
The British Journal of Dermatology
|
February 3, 2016
Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB-IVA mycosis fungoides/Sézary syndrome
F Child, P L Ortiz-Romero, R Alvarez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2011
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial
F Egberts, R Gutzmer, S Ugurel, et al.
Page
of 6